These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31415723)

  • 1. Botulinum toxin and surgical intervention in children and adolescents with cerebral palsy: who, when and why do we treat?
    Valentine J; Davidson SA; Bear N; Blair E; Ward R; Thornton A; Stannage K; Watson L; Forbes D; Elliott C
    Disabil Rehabil; 2021 Apr; 43(7):936-943. PubMed ID: 31415723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study investigating gross motor function of children with cerebral palsy and GMFCS level II after long-term Botulinum toxin type A use.
    Valentine J; Davidson SA; Bear N; Blair E; Paterson L; Ward R; Forbes D; Elliott C
    BMC Pediatr; 2020 Jan; 20(1):7. PubMed ID: 31906902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of botulinum toxin injections preceding a comprehensive rehabilitation period for children with spastic cerebral palsy: A cost-effectiveness study.
    Schasfoort F; Dallmeijer A; Pangalila R; Catsman C; Stam H; Becher J; Steyerberg E; Polinder S; Bussmann J
    J Rehabil Med; 2018 Jan; 50(1):22-29. PubMed ID: 28949368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review.
    Mesterman R; Gorter JW; Harvey A; Lockhart J; McEwen-Hill J; Margallo K; Goldie N
    J Child Neurol; 2014 Feb; 29(2):210-3. PubMed ID: 23965398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
    Nguyen L; Mesterman R; Gorter JW
    BMC Pediatr; 2018 Jan; 18(1):1. PubMed ID: 29301539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
    Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
    Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
    Franzén M; Hägglund G; Alriksson-Schmidt A
    BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
    Balbaloglu O; Basaran A; Ayoglu H
    J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial.
    Boyd RN; Dobson F; Parrott J; Love S; Oates J; Larson A; Burchall G; Chondros P; Carlin J; Nattrass G; Graham HK
    Eur J Neurol; 2001 Nov; 8 Suppl 5():109-19. PubMed ID: 11851739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of botulinum toxin type A in pediatric patients with cerebral palsy: a three-center retrospective chart review.
    Gormley ME; Gaebler-Spira D; Delgado MR
    J Child Neurol; 2001 Feb; 16(2):113-8. PubMed ID: 11292216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children].
    Dohin B; Garin C; Vanhems P; Kohler R
    Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of botulinum toxin A lower limb injections in addition to physiotherapy approaches in children with cerebral palsy: A systematic review.
    Yana M; Tutuola F; Westwater-Wood S; Kavlak E
    NeuroRehabilitation; 2019; 44(2):175-189. PubMed ID: 30856126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of quantitative gait assessment and botulinum toxin a on musculoskeletal surgery in children with cerebral palsy.
    Molenaers G; Desloovere K; Fabry G; De Cock P
    J Bone Joint Surg Am; 2006 Jan; 88(1):161-70. PubMed ID: 16391261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of botulinum toxin in treatment of spasticity and functional improvements for children suffering from cerebral palsy.
    Meholjic A; Madjar D
    Med Arh; 2010; 64(6):359-61. PubMed ID: 21218755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.
    Ubhi T; Bhakta BB; Ives HL; Allgar V; Roussounis SH
    Arch Dis Child; 2000 Dec; 83(6):481-7. PubMed ID: 11087280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review.
    Pin TW; Elmasry J; Lewis J
    Dev Med Child Neurol; 2013 Apr; 55(4):304-13. PubMed ID: 23095013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
    J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
    Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
    Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.